Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Aug 2026 for SPYRE THERAPEUTICS INC, €449k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Jeffrey Albers: trading record in brief
Our data holds just one disclosure by Jeffrey Albers, dated 7 August 2026, reporting a transaction worth €449k in Spyre Therapeutics, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jeffrey Albers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 5,000 shares@ US$103.42CommonSEC144:0001950047-26-007821
1 of 1 declaration